NUALTIS
Live / Applied — Extension of time to oppose received (as of 08 Jan 2026)
What this means for you
Not registered yet, but its 22 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99149528
- Mark type
- Stylized text
- Filed
- 22 Apr 2025
- Published for opposition
- 09 Dec 2025
- Attorney of record
- Gunther J. Evanina
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents in the form of dissolvable, mucoadhesive, and edible films, wafers, and strips that provide controlled and immediate oral, buccal, sublingual, and transmucosal release of a wide variety of therapeutic agents in the nature of pharmaceuticals, nutraceuticals, vitamins, minerals, and bioactive compounds
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals
- Class 042 — Scientific and technological services: Pharmaceutical consulting services
Owner
- Intelgenx Corporation, St-Laurent, QC, CA
- Intelgenx Corporation, St-Laurent, QC, CA
Prosecution history
- 08 Jan 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Nov 2025 — EXAMINER'S AMENDMENT ENTERED
- 13 Nov 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Nov 2025 — EXAMINERS AMENDMENT E-MAILED
- 13 Nov 2025 — EXAMINERS AMENDMENT -WRITTEN
- 05 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Sept 2025 — NON-FINAL ACTION E-MAILED
- 15 Sept 2025 — NON-FINAL ACTION WRITTEN